Showing results (101-110 of 119) with videos related to
Sort By:
Pageof 12
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 16, 2009
Changes in the subpopulation of CD25+ CD4+ and FOXP3+ regulatory T cells in decidua with respect to the progression of labor at term and the lack of analogical changes in the subpopulation of suppressive B7-H4 macrophages--a preliminary reportKrystyna Galazka, Lukasz Wicherek, Kazimierz Pitynski, et al.Circulation Research|November 20, 2004
Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarctionMagda Kucia, Buddhadeb Dawn, Greg Hunt, et al.European Heart Journal|November 4, 2005
Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarctionWojciech Wojakowski, Michal Tendera, Anna Zebzda, et al.Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|March 27, 2023
Single-photon emission computed tomography as a fundamental tool in evaluation of myocardial reparation and regeneration therapiesŁukasz Tekieli, Wojciech Szot, Ewa Kwiecień, et al.Blood|November 8, 2003
Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrowJanina Ratajczak, Ryan Reca, Magda Kucia, et al.Kardiologia Polska|February 13, 2008
[Visualisation of early engraftment of transcoronary applied CD34+ cells in the infarct border zone]Piotr Musiałek, Wiesława Tracz, Magdalena Kostkiewicz, et al.Blood|September 20, 2002
CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesionJolanta Libura, Justyna Drukala, Marcin Majka, et al.Blood|January 4, 2003
Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1Ryan Reca, Dimitrios Mastellos, Marcin Majka, et al.Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|July 11, 2015
Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man StudyPiotr Musialek, Adam Mazurek, Danuta Jarocha, et al.European Heart Journal|February 12, 2009
Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) TrialMichał Tendera, Wojciech Wojakowski, Witold Ruzyłło, et al.Pageof 12